Try our Advanced Search for more refined results

Bass 'Patent Troll' Ally Seeks Help Targeting Depomed IP

By Ryan Davis (September 29, 2015, 10:17 PM EDT) -- Erich Spangenberg, the so-called patent troll working with hedge fund manager Kyle Bass to challenge patents on drugs they say are overpriced, called Tuesday for volunteers to target the patent for Depomed Inc.'s painkiller Nucynta, saying last week's decision not to sanction Bass means anyone can fight drug patents....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!